December 10, 2020 Ror1 delivers its second takeout in five weeks Boehringer Ingelheim buys NBE-Therapeutics, the second Ror1-focused player to be taken out in just over a month.
June 11, 2020 New Genmab/Abbvie tie-up rings old bells Followers of Nordic Nanovector and Oxford Biomedica, among others, will pay close attention to an early focus of yesterday’s deal.
